Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice

Overview of attention for article published in Inflammation and Regeneration, September 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Readers on

mendeley: 14 Mendeley

Summary X Patents

So far, Altmetric has seen 3 patents that reference this research output.

NOVEL HMGB1-DERIVERED PEPTIDE AND USE THEREOF

Application WO-2023182838-A1

World Intellectual Property Organisation (WIPO)

THERAPEUTIC DRUG FOR FATTY LIVER AND NONALCOHOLIC STEATOHEPATITIS

Application WO-2023053384-A1

World Intellectual Property Organisation (WIPO)

DRUG FOR TREATING FATTY LIVER AND NON-ALCOHOLIC STEATOHEPATITIS

Application WO-2023054666-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.